ASP Isotopes Inc. Common ... (ASPI)
5.33
0.42 (8.55%)
At close: Jan 15, 2025, 11:59 AM
Company Description
ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes.
It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28.
The company also Uranium-235, an isotope of uranium for carbon-free energy industry.
ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
ASP Isotopes Inc. Common Stock
| Country | United States |
| IPO Date | Nov 10, 2022 |
| Industry | Chemicals |
| Sector | Basic Materials |
| Employees | 76 |
| CEO | Paul Elliot Mann C.F.A. |
Contact Details
Address: 433 Plaza Real Boca Raton, Florida United States | |
| Website | aspisotopes.com |
Stock Details
| Ticker Symbol | ASPI |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001921865 |
| CUSIP Number | 00218A105 |
| ISIN Number | US00218A1051 |
| Employer ID | 87-2618235 |
| SIC Code | 2890 |
Key Executives
| Name | Position |
|---|---|
| Dr. Gerdus Kemp M.D., Ph.D. | Medical Director & Chief Executive Officer of Pet Labs |
| Paul Elliot Mann C.F.A. | President, Chief Executive Officer & Executive Chairman |
| Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D. | Chief Technology Officer & Director |
| Heather Kiessling | Chief Financial Officer |
| Robert Ainscow | Chief Operating Officer |
| Dr. Xandra van Heerden Ph.D. | Head of Research & Development |
| Hendrik T. van Wyk | Head of Engineering |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 13, 2025 | 8-K | Current Report |
| Dec 16, 2024 | 8-K | Current Report |
| Dec 13, 2024 | 8-K | Current Report |
| Dec 11, 2024 | 4 | Filing |
| Dec 02, 2024 | 8-K | Current Report |
| Nov 27, 2024 | 8-K | Current Report |
| Nov 26, 2024 | 8-K | Current Report |
| Nov 21, 2024 | 4 | Filing |
| Nov 21, 2024 | 4 | Filing |
| Nov 21, 2024 | 4 | Filing |